Related Experiment Videos
Implantable cardioverter defibrillators in children
Terrence U H Chun1, Kathryn K Collins, Anne M Dubin
1Division of Pediatric Cardiology, Stanford University, 750 Welch Road, Suite 305, Palo Alto, California 94305, USA. tchun@stanford.edu
Expert Review of Cardiovascular Therapy
|July 1, 2004
Summary
Implantable cardioverter defibrillators (ICDs) in children face unique challenges due to device size and hardware limitations. Continued growth potential in pediatric patients impacts lead longevity and device placement considerations.
Area of Science:
- Pediatric Cardiology
- Biomedical Engineering
- Electrophysiology
Background:
- Increasing survival rates for congenital heart defects lead to more adults requiring advanced cardiac care.
- Pediatric patients with repaired congenital heart defects face a risk of late sudden death.
- Current implantable cardioverter defibrillator technology is not optimized for pediatric use.
Purpose of the Study:
- To address the unique challenges of using implantable cardioverter defibrillators in pediatric patients.
- To highlight considerations for device selection and implantation in children.
- To discuss the long-term implications of ICDs in growing pediatric patients.
Main Methods:
- Review of current literature on pediatric ICD implantation.
- Analysis of device limitations in pediatric populations.
- Discussion of anatomical and physiological considerations in children.
Main Results:
- Pediatric cardiologists face challenges with device size and hardware limitations.
- Lead and electrode implications are significant due to patient growth.
- Anatomical variations in pediatric patients affect device placement.
Conclusions:
- Implantable cardioverter defibrillator therapy in children requires specialized considerations.
- Device design and implantation strategies must account for pediatric-specific needs.
- Further research and device development are needed for pediatric ICD use.